Boston Scientific BSX shares are trading lower on Tuesday after the company announced a global voluntary recall and discontinuation of its LOTUS Edge aortic valve system due to complexities with the delivery system.
Boston Scientific produces less-invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract tests, interventional oncology, and treatment of incontinence.
Boston Scientific shares were trading down 10.20% at $34.16 on Tuesday during the time of publication. The stock has a 52-week high of $46.62 and a 52-week low of $24.10.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.